ARTICLE | Strategy
Accelerating Flatiron
How Roche acquisition accelerates expansion of Flatiron’s real-world data platform
March 9, 2018 4:35 PM UTC
Roche isn’t saying much about how it approached the decision to shell out $1.9 billion to acquire the 87% of Flatiron Health Inc. it didn’t already own. But it appears that Flatiron would have needed to scale back or at least slow down development of its real-world data platform as a stand-alone company.
Since Roche is counting on those data to accelerate development of its cancer pipeline, ensuring that Flatiron had the resources to develop the platform quickly made strategic sense...